Novel Bayesian classification models for predicting compounds blocking hERG potassium channels

被引:46
作者
Liu, Li-li [1 ]
Lu, Jing [1 ,2 ]
Lu, Yin [1 ]
Zheng, Ming-yue [1 ]
Luo, Xiao-min [1 ]
Zhu, Wei-liang [1 ]
Jiang, Hua-liang [1 ,3 ]
Chen, Kai-xian [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China
[2] Yantai Univ, Sch Pharm, Dept Med Chem, Yantai 264005, Peoples R China
[3] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
hERG; potassium channels; long QT syndrome; pharmacophore; modeling; Laplacian-modified Bayesian; extended-connectivity fingerprints; QSAR; VECTOR MACHINE METHOD; K+ CHANNEL; QSAR MODEL; INHIBITION; INSIGHTS; PHARMACOPHORE; DESCRIPTORS; GENERATION; LIABILITY; AFFINITY;
D O I
10.1038/aps.2014.35
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: A large number of drug-induced long QT syndromes are ascribed to blockage of hERG potassium channels. The aim of this study was to construct novel computational models to predict compounds blocking hERG channels. Methods: Doddareddy's hERG blockage data containing 2644 compounds were used, which divided into training (2389) and test (255) sets. Laplacian-corrected Bayesian classification models were constructed using Discovery Studio. The models were internally validated with the training set of compounds, and then applied to the test set for validation. Doddareddy's experimentally validated dataset with 60 compounds was used for external test set validation. Results: A Bayesian classification model considering the effects of four molecular properties (M-w, PPSA, ALogP and pK(a)_basic) as well as extended-connectivity fingerprints (ECFP_14) exhibited a global accuracy (91%), parameter sensitivity (90%) and specificity (92%) in the test set validation, and a global accuracy (58%), parameter sensitivity (61%) and specificity (57%) in the external test set validation. Conclusion: The novel model is better than those in the literatures for predicting compounds blocking hERG channels, and can be used for large-scale prediction.
引用
收藏
页码:1093 / 1102
页数:10
相关论文
共 54 条
[1]   Prediction of herg K+ blocking potency:: Application of structural knowledge [J].
Aptula, AO ;
Cronin, MTD .
SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2004, 15 (5-6) :399-411
[2]   Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers [J].
Aronov, Alex M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) :6917-6921
[3]   A model for identifying HERG K+ channel blockers [J].
Aronov, AM ;
Goldman, BB .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (09) :2307-2315
[4]   Predictive in silico modeling for hERG channelblockers [J].
Aronov, MM .
DRUG DISCOVERY TODAY, 2005, 10 (02) :149-155
[5]   hERG channel function: beyond long QT [J].
Babcock, Joseph J. ;
Li, Min .
ACTA PHARMACOLOGICA SINICA, 2013, 34 (03) :329-335
[6]   HERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study [J].
Bains, W ;
Basman, A ;
White, C .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2004, 86 (02) :205-233
[7]   Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers [J].
Cavalli, A ;
Poluzzi, E ;
De Ponti, F ;
Recanatini, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3844-3853
[8]   Shape signatures: New descriptors for predicting cardiotoxicity in silico [J].
Chekmarev, Dmitriy S. ;
Kholodovych, Vladyslav ;
Balakin, Konstantin V. ;
Ivanenkov, Yan ;
Ekins, Sean ;
Welsh, William J. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (06) :1304-1314
[9]   ADME Evaluation in Drug Discovery. 10. Predictions of P-Glycoprotein Inhibitors Using Recursive Partitioning and Naive Bayesian Classification Techniques [J].
Chen, Lei ;
Li, Youyong ;
Zhao, Qing ;
Peng, Hui ;
Hou, Tingjun .
MOLECULAR PHARMACEUTICS, 2011, 8 (03) :889-900
[10]   Predictive models for hERG potassium channel blockers [J].
Cianchetta, G ;
Li, Y ;
Kang, JS ;
Rampe, D ;
Fravolini, A ;
Cruciani, G ;
Vaz, RJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (15) :3637-3642